Looking for an "all-natural" diabetes cure-all? Then click here for Glucobate.
Glucobate's a phony ad for a phony product created by the Federal Trade Commission (FTC) to alert consumers to the dangers of diabetes treatment scams on the Internet.
That's how BIG diabetes Internet scams have become -- to the point where the FTC and the FDA are collaborating to such lengths as producing a bait-and-switch ad campaign in the US, Mexico, and Canada to alert consumers about protecting themselves from diabetes-related health fraud.
The FTC attorney who wrote to me says they've sent warning letters to 180 websites peddling bogus diabetes "cures" -- herbs, teas, supplements, and the like.
The savvy Glucobate tagline is "be smart, be skeptical." Which seems so intuitive, of course. But you'd be surprised how convincing some of the bogus product sites can be. And of course, there comes a point in many a PWD's life where they'd simply try anything. Understood.
But visit the Glucobate site to review seven helpful tips for evaluating diabetes products, as well as buttons and banners we online types can use to spread the word.
Bogus cures, be gone!
Welcome back to our weekly diabetes advice column, Ask D'Mine, hosted by veteran type 1, diabetes author and educator Wil Dubois. This week is a downer, for sure, so make sure you have your tissue box handy... Wil responds to a scared sister's qu...
Some of you may know from following us on social media that I've been under the weather over the holidays. Yuck!For the past month, I've had a cold and persistent cough that have been messing with my diabetes management.With it being the start of ...
In a world where any little question can take on a life of its own... A good reminder not to be like those diabetes police pestering us about blood sugars!Thanks to the artistic Gareth Morgan, a fellow type 1 in England and biomedical researcher...
Happy Saturday! Welcome to Ask D'Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois. We've had some "back to basics" questions piling up at the bottom of the mailbag, and while some may seem...
As part of our continuing coverage on the Insulin Affordability Crisis, in the Fall we "followed the money trail" to Pharmacy Benefit Managers, and we're now looking at them more closely. Special thanks to our correspondent Dan Fleshler for his he...